Nowhere have the consequences been clearer than in Europe, which bet heavily on AstraZeneca vaccine doses but has received just a third of what was promised. (Joshua Carroll/The Washington Post)Bumpy scienceThe AstraZeneca vaccine surfed a wave of hype last spring. He questioned why the AstraZeneca vaccine had to be subjected to further trials before being authorized in the United States. Some said the United States does not need the AstraZeneca vaccine, no matter what its efficacy. “I don’t see any role for the AstraZeneca vaccine in the U.S.,” said Eric Topol, founder and director of Scripps Research Translational Institute.

Source: Washington Post March 21, 2021 20:09 UTC